Will the Innovative Medicines Initiative really deliver innovative medicines?

被引：1

|

作者：

Wilkinson, Emma

机构：

来源：

MOLECULAR ONCOLOGY | 2008年 / 2卷 / 03期

关键词：

D O I：

10.1016/j.molonc.2008.07.007

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：203 / 205

页数：3

相关论文

共 50 条

[21] Biomarkers for disease modification trials - The innovative medicines initiative and AddNeuroMed
Lovestone, S.
Francis, P.
Strandgaard, K.
JOURNAL OF NUTRITION HEALTH & AGING, 2007, 11 (04): : 359 - 361
[22] Innovative Medicines Initiative plays the long game on research funding
Meulien, Pierre
NATURE MICROBIOLOGY, 2021, 6 (02) : 137 - 137
[23] Innovative Medicines Initiative plays the long game on research funding
Pierre Meulien
Nature Microbiology, 2021, 6 : 137 - 137
[24] INNOVATIVE VERSUS GENERIC MEDICINES
KEEN, PJ
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1991, 84 (06) : 375 - 378
[25] The innovative medicines initiative (IMI): a shot in the arm for European diabetes research?
Halban, P. A.
DIABETOLOGIA, 2007, 50 (09) : 1791 - 1794
[26] Innovative medicines initiative: From semantic data integration to risk assessment
Digles, Daniela
Goldmann, Daria
Zdrazil, Barbara
Ecker, Gerhard
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
[27] The Rational Use of Animals in Drug Development: Contribution of the Innovative Medicines Initiative
Gunn, Magda
Vaudano, Elisabetta
Goldman, Michel
ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 2012, 40 (06): : 307 - 312
[28] Reflections on the Innovative Medicines Initiative (vol 10, pg 321, 2011)
Goldman, Michel
NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (06) : 475 - 475
[29] The innovative medicines initiative (IMI): a shot in the arm for European diabetes research?
P. A. Halban
Diabetologia, 2007, 50 : 1791 - 1794
[30] In silico prediction of in vivo toxicities (eTox)-The Innovative Medicines Initiative Approach
Steger-Hartmann, Thomas
Pognan, Francois
Sanz, Ferran
Acedo Diaz, Carlos
TOXICOLOGY LETTERS, 2009, 189 : S258 - S258

← 1 2 3 4 5 →